Dermira Doses First Patient in DRM01 Phase 2b Acne Trial
April 09, 2015 07:30 ET
|
Dermira, Inc.
MENLO PARK, Calif., April 9, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...
Dermira to Present at the 14th Annual Needham Healthcare Conference
April 08, 2015 07:30 ET
|
Dermira, Inc.
MENLO PARK, Calif., April 8, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...
Dermira Reports Fourth Quarter and Full Year 2014 Financial Results and Provides Corporate Update
March 25, 2015 16:09 ET
|
Dermira, Inc.
DRM01 Phase 2b Trial in Acne to Start April 2015
Conference Call Today at 4:30 p.m. Eastern Time
MENLO PARK, Calif., March 25, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty...
Clinical Data for Dermira's DRM01 Acne Program Presented at Dermatology Meeting
March 23, 2015 07:00 ET
|
Dermira, Inc.
MENLO PARK, Calif., March 23, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...
Dermira to Report Fourth Quarter and Full Year 2014 Financial Results
March 18, 2015 16:05 ET
|
Dermira, Inc.
MENLO PARK, Calif., March 18, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated dermatology products to...
Dermira Announces Late-Breaking Oral Presentation on DRM01 in Acne at 2015 AAD Annual Meeting
March 12, 2015 16:05 ET
|
Dermira, Inc.
MENLO PARK, Calif., March 12, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...